VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹119 Cr | ₹60 Cr | ₹29 Cr | ₹51 Cr |
What is the latest Total Current Liabilities ratio of VALIANT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹119 Cr |
| Mar2025 | ₹60 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹51 Cr |
How is Total Current Liabilities of VALIANT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹119 Cr | 100.36 | |
| Mar2025 | ₹60 Cr | 105.03 | |
| Mar2024 | ₹29 Cr | -42.68 | |
| Mar2023 | ₹51 Cr | - | |
Compare Total Current Liabilities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹694.5 Cr | 1% | 4.9% | 52.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | 1% |
4.9% |
52.3% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses